August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
Federal cuts from President Trump's Department of Government Efficiency, or DOGE, have put researchers around the country in ...
The federal government is pledging $675 million for vaccination programs aimed at children in developing countries.
The World Health Organization (WHO) declared an international medical emergency in mid-August because of a disturbing outbreak of a new, more deadly variant of mpox, also known as monkeypox, in Africa ...
We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which ...
Protein vaccines are composed of purified or recombinant proteinaceous antigens from a pathogen, such as a bacterium or virus. When administered, a protective immune response is elicited against ...
About the vaccine, how it works, how it is given, ingredients, allergies, possible side effects, safety monitoring ...
Earlier monkeypox guidelines emphasized containment in endemic areas, principally by isolation and smallpox-based vaccines, which carried greater risks of side effects, particularly in ...
Mpox, previously known as monkeypox, is a viral illness caused ... Uganda received only 10,000 doses of the Mpox vaccine which were given to commercial sex workers in the Kampala metropolitan ...
The MMR vaccine protects you from measles, mumps, and rubella. All three of these diseases spread easily, so it's important to get this vaccine. (Photo Credit: E+/Getty Images) Adults who were ...